A Diabetes Study to Treat A Population Previously Not at Target
NCT00747149
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
598
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Rosuvastatin
Sponsor
AstraZeneca